The global idiopathic pulmonary fibrosis market is projected to grow from USD 4.4 billion to USD 8.6 billion by 2035, representing a healthy CAGR of 7.0% during the forecast period. According to the American Lung Association data, nearly 50,000 new cases of idiopathic pulmonary fibrosis have been reported annually. The growing awareness about idiopathic pulmonary fibrosis amongst healthcare experts and patients has surged the demand for therapeutic drugs and diagnosis procedures to mitigate the...

The global single nucleotide polymorphism (SNP) genotyping market is expected to grow from USD 12.9 billion in 2025 to USD 61.1 billion by 2035, representing a CAGR of 16.84% during the forecast period. One of the significant single nucleotide polymorphisms (SNP) genotyping market driver is rising incidence of chronic diseases such as diabetes and cancer. According to the National Cancer Institute, in 2024, nearly 14,910 children and adolescents aged (0-19 years) will be diagnosed with cancer. T...

The global genomics market size, valued at USD 38.77 billion in 2024, is expected to reach USD 46.06 billion in 2025 and USD 186.64 billion by 2035, representing a compounded annual growth rate (CAGR) of 15.0% during the forecast period. Some of the potential market drivers that are anticipated to drive the genomics market growth includes rising prevalence of cancer and growing adoption of next generation sequencing in cancer research. As per the cancer statistics published by American Cancer So...

The global cannabidiol market size is estimated to increase from USD 8.52 billion in 2024 to reach USD 41.42 billion by 2035, representing a CAGR of 15.46% during the forecast period. According to the recent report of Centers for Disease Control and Prevention, close to 129 million people in United States are suffering from at least one chronic condition. Such patients require prolonged medication for the management of disease conditions and associated pain. Notably, there is a rapid increase in...

The global synthetic biology market is projected to grow from USD 23.88 billion in 2025 to USD 130.67 billion by 2035, representing a compounded annual growth rate of 18.53% during the forecast period. It is important to note here that Genomatica has achieved success in the development of microorganism-based production process (Geno proprietary technology) that converts renewable carbon of sugar plants into precursor to nylon (100% renewable carbon-based nylon-6). Furthermore, top fashion brands...

The global agricultural pheromones market is estimated to grow from USD 4.9 billion in 2024 to USD 15.3 billion by 2032. The market is projected to grow at a higher CAGR value of 15.3% during the forecast period. The global agricultural pheromones market is segmented into sex pheromones, aggregation pheromones, repellent pheromones, and others. According to our market study analysis, Sex pheromones account for the largest share, capturing 86% of the overall revenue share of the market in 2024. T...

The modular pharmaceutical construction market is likely to grow from USD 2.5 billion in 2024 to reach USD 2.8 billion in 2025 and USD 7.7 billion by 2035, representing a higher CAGR of 10.7% during the forecast period from 2025 to 2035. In terms of type of modular construction, the relocatable segment holds the highest share (close to 60%) of the market. With regards to size of facility, the very large segment dominates the global market with close to 40% market share. In terms of type of modu...

The global biotechnology market size is valued at 1.57 trillion in 2024 and is poised to reach USD 8.01 trillion by 2035, representing a CAGR of 15.98% during the forecast period. The increasing foothold of advanced drug formulation and personalized medicine are opening new opportunities for biotechnology companies to make investments for driving innovations. It is worth noting here that as of March 2022, The World Health Organization reported that around 11 billion doses of COVID-19 vaccines ha...

The global biopolymers market, valued at USD 9.31 billion in 2024, is projected to reach USD 11.08 billion in 2025 and USD 62.88 billion by 2035, representing a CAGR of 18.96% during the forecast period. Currently, the starch-based polymers accounts for the highest share (35%) of the market. Among these end users, currently packaging accounts for the highest biopolymers market share (57%). Europe holds the highest share (39%) of the market owing to the rising demand for biodegradable and sustain...

The global next generation sequencing services market is estimated to reach USD 12.2 billion in 2025, increasing to USD 87.5 billion by 2035, representing a CAGR of 21.78% during the forecast period. North America maintains a well-established technology manufacturers network and supportive regulatory guidelines for using genetic tests. Additionally, the advanced healthcare infrastructure and rising focus on oncology precision medicine is another significant driver of the next generation sequenci...

Digital psychotherapeutics market is estimated to be USD 2.14 billion in 2025 and is poised to reach USD 25.71 billion by 2035, representing a CAGR of 28.2% during the forecast period. According to a recent report published by the American Psychiatric Association, in 2024, nearly 43% of the adult population is suffering from anxiety. Moreover, the World Health Organization reported that around 280 million people across the globe have depression and over 700,000 people annually die due to severe...

The global regenerative medicine market is valued at USD 13.8 billion in 2024 and is poised to reach USD 57.0 billion by 2035. It is expected to expand at a higher CAGR of ~14% during the forecast period. This promising field is receiving support from various industrial and government organizations to identify the potential of regenerative medicine beyond tissue repair. For instance, in March 2024, Pandorum Technologies (an India-based Biotechnology Company) announced securing USD 11 million dur...

The global orphan drug market size is expected to grow from USD 236.27 billion in 2025 to reach USD 667.48 billion by 2035, representing a CAGR of 10.94% over the forecast period. With rising risk of rare diseases and some rare oncological disorders, the demand for orphan drugs has significantly increased to treat patients. A recent report published by National Center for Advancing Translational Sciences highlighted that nearly 10,000 rare diseases affect the US population. Moreover, according t...

The global amyotrophic lateral sclerosis market size is valued at USD 0.79 billion in 2024 and is estimated to reach USD 1.38 billion by 2035, representing a CAGR of 5.2% during the forecast period. It is important to highlight here that in May 2024, European Medicines Agency (EMA) approved Biogen

The global meditation market size is estimated to grow from USD 8.87 billion in 2025 to USD 37.53 billion by 2035, representing a CAGR of 15.52% during the forecast period. In November 2024, Headspace announced the collaboration with World of Hyatt, in order to offer five-episode video series for the latter

The global radiopharmaceutical manufacturing market is estimated to grow from $3.7 billion in 2024 to $9.0 billion by 2035, representing a CAGR of 8.44% during the forecast period till 2035. It is worth highlighting that around 40 million diagnostic procedures are conducted, annually, which specifically utilize only one radioisotope, Technitium-99m. Typically, diagnostic tests are performed by using highly specialized imaging solutions, such as single photon emission computed tomography (SPECT)...

The global biologics market size is worth around $411 billion in 2024 and is expected to reach $962 billion by 2035, representing a higher compounded annual growth rate (CAGR) of 8.04% during the forecast period. According to the World Health Organization report, nearly 422 million people across the globe are suffering from diabetes. Moreover, nearly 41 million people die annually due to non-communicable diseases, which is equivalent to around 74% of all deaths occurring across the globe. The ri...

The global monoclonal antibodies in veterinary health market is estimated to grow from USD 0.8 billion in 2024 to USD 4.3 billion by 2035, representing a higher CAGR of 17% during the forecast period. According to the report of the American Veterinary Medical Association, nearly 1 out of 4 dogs are estimated to have neoplasia (a form of cancer). The increasing incidence of cancer in companion animals, particularly in dogs, has underscored the requirement of advanced therapeutics to eradicate can...

The global cell and gene therapy CRO market, valued at USD 1.7 billion in 2024, is estimated to reach USD 1.9 billion in 2025 and USD 3.5 billion by 2035, representing a CAGR of 6.3% during the forecast period. Presently, over 90 cell and gene therapies have been approved globally. Notable examples of recently approved therapies include (in reverse chronological order of year of approval) Fucaso (2023; developed by IASO Bio) for the treatment of multiple myeloma, Elvediys, (2023; developed by Sa...

The global medical tourism market size is estimated to grow from USD 33.78 billion in 2024 to USD 176.17 billion by 2035, representing a CAGR of 16.20% during the forecast period. Medical tourism is a common practice of traveling to different destinations and across international borders for healthcare facilities. With rising disposable income, medical insurance coverages and growing preferences for advanced healthcare services, medical tourism is booming across the globe. According to the recen...